CTRI/2018/03/012441
Completed
未知
Effect of Hypofractionated Palliative Radiotherapy on Quality of Life in Late Stage Oral Cavity Cancer:A Prospective clinical Trial
Jawaharlal Institue of Postgraduate Medical Education and research0 sites25 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Jawaharlal Institue of Postgraduate Medical Education and research
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •i)Biopsy proven Squamous cell carcinoma
- •ii)Surgically unresectable stage IVB oral cavity cancer where oral cavity is defined as consisting of lip, alveolus, floor of mouth, hard palate, retromolar trigone, buccal mucosa and tongue (extension to infratemporal fossa extension,masticator space, pterygoid plates, or skull bases or encases internal carotid artery )
- •iii)Stage IVA disease\- not fit for surgery/ curative treatment
- •iv)Stage IVC disease\-for palliation of local symptoms
- •v)No previous history of radiotherapy/chemotherapy/surgery
- •vi)No previous history of cancer
Exclusion Criteria
- •i)Patients with another primary at a different site
- •ii)Pregnant women
- •iii)Age \<18 and \>80 years
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Higher cumulative dose, 6days/week vs standard, 5days/week moderately hypofractionated palliative radiotherapy with concurrent chemotherapy in locally advanced head and neck carcinoma.CTRI/2023/10/058621AIIMS, New Delhi
Active, not recruiting
Not Applicable
Sequential hypofractionated radiotherapy followed by anti-PD-L1 atezolizumab for recurrent or refractory small cell lung cancerKCT0005443ational Cancer Center35
Completed
Phase 1
Hypofractionated radiotherapy for low and intermediate-risk prostate cancer using robot-tracking stereotactic radiotherapy -phase I/II clinical trialprostate cancerJPRN-UMIN000014328Osaka University Graduate School of Medicine75
Recruiting
Phase 3
A study comparing a one week schedule of radiotherapy versus a three week schedule of radiotherapy given after surgery for breast cancerCTRI/2018/12/016816Tata Medical Center
Active, not recruiting
Not Applicable
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in adenocarcinoma of the esophagus or esophogastric junction trial - a phase II clinical trial protocol.EUCTR2014-002362-74-SESkåne University Hospital, Department of Oncology